Unraveling the Complex Interplay between Epigenetics and Immunity in Alcohol-Associated Liver Disease: A Comprehensive Review

被引:6
|
作者
Liu, Yali [1 ]
Liu, Tao [1 ]
Zhang, Feiyu [1 ]
Gao, Yanhang [1 ]
机构
[1] Jilin Univ, First Hosp Jilin Univ, Dept Hepatol, Changchun 130021, Jilin, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
alcohol-associated liver disease; immune microenvironment; epigenetic modifications; exosomes; cytokines and chemokines; S-ADENOSYLMETHIONINE; DNA METHYLATION; HISTONE H3; METHIONINE ADENOSYLTRANSFERASE; EXTRACELLULAR VESICLES; CELL ACTIVATION; ACETYLATION; ETHANOL; STRESS; INJURY;
D O I
10.7150/ijbs.87975
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms of immune dysfunction in alcohol-associated liver disease (ALD) have garnered growing research interest in recent times. Alcohol-mediated immune dysfunction has been implicated as a potential cause of ALD-associated microbial infection and inflammatory response. The immune microenvironment of an organism is essentially a complex network of interactions between immune cells, cytokines, extracellular matrix, and other immune-related molecules. This microenvironment is highly adaptive and responsive to environmental cues. Epigenetic reprogramming of the immune microenvironment has recently emerged as a key driver of ALD progression, particularly in the context of endotoxin tolerance and immune disorders. Although epigenetic modifications are known to play an important role in the regulation of the immune microenvironment in ALD, the specific mechanisms and molecular processes by which this regulation is achieved are yet to be fully understood. This paper aims to provide an overview of the current knowledge on the effects of alcohol consumption on epigenetics, with special focus on summarizing the data on the epigenetic regulatory mechanisms involved in the effects of alcohol consumption on the immune microenvironment. In addition, this paper aims to present a review of the epigenetic modifications involved in different forms of ALD. This review is expected to offer new perspectives for the diagnosis, treatment, monitoring, and prognostic assessment of ALD from an epigenetic perspective.
引用
收藏
页码:4811 / 4830
页数:20
相关论文
共 50 条
  • [41] Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy
    Subramaniyan, Vetriselvan
    Chakravarthi, Srikumar
    Jegasothy, Ravindran
    Seng, Wu Yuan
    Fuloria, Neeraj Kumar
    Fuloria, Shivkanya
    Hazarika, Iswar
    Das, Anju
    TOXICOLOGY REPORTS, 2021, 8 : 376 - 385
  • [42] Role of the ghrelin system in alcohol use disorder and alcohol-associated liver disease: A narrative review
    Kharbanda, Kusum K.
    Farokhnia, Mehdi
    Deschaine, Sara L.
    Bhargava, Raghav
    Rodriguez-Flores, Marcela
    Casey, Carol A.
    Goldstone, Anthony P.
    Jerlhag, Elisabet
    Leggio, Lorenzo
    Rasineni, Karuna
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 (12): : 2149 - 2159
  • [43] Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis
    Amonker, Sachin
    Houshmand, Aryo
    Hinkson, Alexander
    Rowe, Ian
    Parker, Richard
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (05)
  • [44] Integrated Multidisciplinary Management of Alcohol-Associated Liver Disease
    Holbeck, Malia
    DeVries, Hannah Statz
    Singal, Ashwani K.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (06) : 1404 - 1412
  • [45] Alcohol-Associated Liver Disease: Evolving Concepts and Treatments
    David Stephen Prince
    Emily Nash
    Ken Liu
    Drugs, 2023, 83 : 1459 - 1474
  • [46] Alcohol-associated liver disease: The time to act is now
    Malhi, Harmeet
    Gores, Gregory J.
    HEPATOLOGY, 2024,
  • [47] Alcohol-Associated Liver Disease - From Pathogenesis to Treatment
    Singal, Ashwani K.
    Anand, Anil C.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (03) : 387 - 389
  • [48] The circulating proteomic signature of alcohol-associated liver disease
    Luther, Jay
    Vannier, Augustin G. L.
    Schaefer, Esperance A.
    Goodman, Russell P.
    JCI INSIGHT, 2022, 7 (14)
  • [49] Harnessing the Proteostasis Network in Alcohol-associated Liver Disease
    Choudhury, Asmita
    Mandrekar, Pranoti
    CURRENT PATHOBIOLOGY REPORTS, 2020, 8 (03) : 47 - 59
  • [50] Elafibranor: A promising treatment for alcohol-associated liver disease?
    Wei, Hong
    Sang, Li-Xuan
    Chang, Bing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (39)